about
Chronic immune activation and inflammation as the cause of malignancyMesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumorPutting tumours in contextThe p53-dependent effects of macrophage migration inhibitory factor revealed by gene targetingNon-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-kappaB by inhibiting both its nuclear localization and ability to bind DNAInhibitory effect of nuclear factor-κB decoy oligodeoxynucleotide on liver fibrosis through regulation of the epithelial-mesenchymal transition.Nitric oxide donors.Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T-cell-mediated skin disease. Viewpoint.Review article: inflammation-related promotion of gastrointestinal carcinogenesis--a perigenetic pathway.Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide.BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression.Potential of soluble CD26 as a serum marker for colorectal cancer detection.Review article: colitis-associated cancer -- time for new strategies.Epithelial-Mesenchymal Transition in tumor microenvironment.Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.CON: surveillance for ulcerative colitis-associated cancer: time to change the endoscopy and the microscopy.DNA repair is indispensable for survival after acute inflammation.Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early-stage cervical cancer and lymphatic metastasisFatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.Deficiencies of GM-CSF and interferon gamma link inflammation and cancerTargeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP.Formal modeling and analysis of the hexosamine biosynthetic pathway: role of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression.Latent Tuberculosis Infection and the Risk of Subsequent Cancer.Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.Epithelial-mesenchymal Transition and Cell Invasion.IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients.Acetamides: chemotherapeutic agents for inflammation-associated cancers.CD74 is a survival receptor on colon epithelial cells.Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells.Low concentration of S100A8/9 promotes angiogenesis-related activity of vascular endothelial cells: bridges among inflammation, angiogenesis, and tumorigenesis?Paracrine cyclooxygenase-2-mediated signalling by macrophages promotes tumorigenic progression of intestinal epithelial cells.Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats.
P2860
Q24648532-BC29EC49-4077-4F54-A6AC-EA374EDB428EQ27320784-B2B480A5-D942-4450-98DE-3D506A2A203AQ28207789-2FB7A835-44E9-4720-B60A-0210088DF328Q28588064-B3E95F5F-B52A-4EA2-A13E-1B00AE9A9680Q33664095-1FC91CCC-C4EC-46B9-903E-8AEE81A49F48Q33744153-D17F6339-22D3-41C7-89BD-839034D6BA35Q33944713-3DAD3381-95DE-4ACF-B618-DB7FC2B2F9B6Q34063617-C732BC4E-96E2-45DC-993F-426287082B28Q34084629-C9223F1B-8372-4351-BD20-B2D20296C711Q34135765-EB6625F1-DA2E-4555-B834-5072B5CBE8C8Q34223460-33F2C507-A057-47C2-8290-4928F6C2B6CDQ34400157-4E4C28C2-EEC7-4B92-B101-E5C33485B2D1Q34972203-830E53FF-018A-4A80-AE59-FC3C2BC70384Q35113393-E7D47B29-B6A2-4FB1-9870-A072B98A0FD2Q35209646-E6FD5DB6-030F-482A-8F20-F844F463216FQ35230386-27CC3295-6438-469D-90DE-915357628FD0Q35762790-3DA4D3E5-7C66-48F4-B22D-3A35120E582CQ35872037-67D33712-02E9-41A5-97F4-701496F25763Q36068346-93DE21FA-E1EF-4FA5-AA42-2876D734A4D5Q36121382-4CA2C25A-C8BD-4C58-B4CE-736B48F0306EQ36369031-E7D2A6E3-B65F-4CC4-9908-706A6239D4B3Q36370994-4BEC2A27-C64F-4976-ADDA-F6142000C2CDQ36843035-B3B63BDB-3916-4BF4-9840-6A001F41CCA8Q37059917-CACE8A3B-E182-446B-A393-D4E22594DC9BQ37115176-63210295-EC66-4540-BD6E-783860187663Q37305086-7FC9D213-6F89-4269-BD07-F26630349BC3Q37624046-555E4371-9A06-4C19-859D-F67E82407518Q37668231-B3846981-BC8B-4161-A075-3117E307AC14Q38166350-00C26FF6-D7CF-4853-8F0B-F5AD3F0936FEQ38256438-267C55DE-DEA3-43B3-A03D-3FEA4119F507Q38551665-817148BF-6C93-4B65-AE6E-85F8FF03B1EDQ39682893-D370E37C-92C4-4E11-8EB1-838CB9FA4048Q40425709-35E6BE78-6DDD-4AF7-AC24-DD3902C92F91Q41932796-C9FBC34A-02B9-48CB-9B80-E347044CF0F3Q44172463-BF904834-EBBC-478A-9909-9158BD7080CEQ45038997-B7769C01-A904-4835-97F6-C517ED85E065Q46888790-D120D84C-98ED-4F82-9AA5-D17DC593580E
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
At the crossroads of inflammation and tumorigenesis.
@en
type
label
At the crossroads of inflammation and tumorigenesis.
@en
prefLabel
At the crossroads of inflammation and tumorigenesis.
@en
P2860
P356
P1476
At the crossroads of inflammation and tumorigenesis.
@en
P2093
Cordon-Cardo C
P2860
P304
P356
10.1084/JEM.190.10.1367
P407
P577
1999-11-01T00:00:00Z